Posted inCardiology news
Hormone Therapy for Hot Flashes: Safe and Effective for Women 50–59, Harm Signals After Age 70 — New WHI Secondary Analysis Clarifies Cardiovascular Risk by Age
A WHI secondary analysis finds that oral conjugated estrogens (with or without MPA) relieve vasomotor symptoms in women 50–59 without clear ASCVD harm, but starting HT in women ≥70 is associated with increased atherosclerotic cardiovascular disease.
